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Aaron M. Swomleya,c,1, Judy C. Tripletta,c,1, Jeriel T. Keeneya, Govind Warriera, Kevin J. 
Pearsonc,d, Julie A. Mattisone, Rafael de Caboe, Jian Caib, Jon B. Kleinb, and D. Allan 
Butterfielda,c,*
aDepartment of Chemistry, University of Kentucky, Lexington, KY 40536, USA
bProteomics Center, University of Louisville, Louisville, KY 40202, USA
cSanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA
dMolecular and Biomedical Pharmacology and Nutrition, University of Kentucky, Lexington, KY 
40536, USA
eTranslational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD 21224, USA
Abstract
A diet consisting of a high intake of saturated fat and refined sugars is characteristic of a Western-
diet and has been shown to have a substantial negative effect on human health. Expression 
proteomics were used to investigate changes to the parietal lobe proteome of rhesus monkeys 
consuming either a high fat and sugar (HFS) diet, a HFS diet supplemented with resveratrol (HFS
+RSV), or a healthy control diet for 2 years. Here we discuss the modifications in the levels of 12 
specific proteins involved in various cellular systems including metabolism, neurotransmission, 
structural integrity, and general cellular signaling following a nutritional intervention. Our results 
contribute to a better understanding of the mechanisms by which resveratrol functions through the 
up- or down-regulation of proteins in different cellular sub-systems to affect the overall health of 
the brain.
Keywords
Resveratrol; Proteomics; Western diet; Rhesus monkey; Brain
1. Introduction
The Western diet has been under much scrutiny in the past couple of decades due to the 
abundance of saturated fat and refined sugar (HFS) content commonly used in food 
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preparation. Long term consumption of HFS has been linked to a number of physiological 
conditions such as obesity, insulin resistance and type-2 diabetes mellitus, cardiac disease, 
ischemia, cancer, and cognitive dysfunction [1]. The projected costs of obesity-related 
diseases are measured not only in monetary terms, but also in life-years used to treat the 
disease and life-years lost to early death associated with obesity and unhealthy diets in 
general.
Resveratrol (RSV) is a polyphenol found primarily in red grapes, blueberries, cranberries, 
nuts such as peanuts and pistachios, as well as in cocoa. RSV has garnered widespread 
acclaim due to the many studies linking it to beneficial effects such as neuroprotection, anti-
inflammation, regulation of metabolic pathways, improved glucose tolerance, and as an 
antioxidant [2–5]. The mode of action for RSV appears to be its indirect activation of the 
NAD+-dependent deacetylase, sirtuin-1 (SIRT1),possibly through the inhibition of cyclic 
AMP (cAMP)-degrading phosphodiesterase, that leads to the deacetylation of the p65 
subunit of NF-κB [6–9].
The parietal lobe of the brain is primarily responsible for the integration of sensory 
information, both tactile and perceived, as well as spatial recognition and processing of both 
language and memory. Impairments to the parietal lobe are seen in a number of 
neurodegerative diseases such as Alzheimer disease (AD), Parkinson disease, and 
amyotrophic lateral sclerosis [10–12]. AD in particular, along with its earlier stage, 
amnestic-mild cognitive impairment (aMCI), have been linked to proteome dysfunction in 
most regions of the brain, including parietal lobule, indicating that a healthy and functioning 
proteome is necessary for normal brain function [13,14]. Although there has been 
considerable research on the effects of RSV in a number of scenarios and models, a 
proteomic analysis of the primate brain has yet to be conducted. With 95% genetic 
homology, rhesus monkeys are an ideal translational model toward understanding the effects 
of a Westernized diet and the influence of RSV supplementation in a primate brain, 
modeling humans. Through the use of discovery-based proteomics methodology, the current 
study led to the identification of parietal proteins important in energy production, cellular 
signaling, and neurotransmission within the proteome of rhesus monkey parietal lobe which 
might play a role in neurodegenerative disease or dysfunction associated with an unhealthy 
diet.
2. Materials
The chemicals used in these experiments were purchased from Sigma-Aldrich (St. Louis, 
MO, USA) with the following exceptions: Criterion precast polyacrylamide gels, 
ReadyStrip™ IPG strips (pH 3–10), Precision Plus Protein™ All Blue Standards, Sypro 
Ruby Protein Stain, MOPS and TGS running buffers, 0.2 nm nitrocellulose membrane, 
mineral oil, dithiothreitol, iodoacetamide, biolytes, and urea were purchased from Bio-Rad 
(Hercules, CA, USA).Modified trypsin solution was obtained from Promega (Madison, WI, 
USA) and C18 ZipTips were acquired from Millipore (Billerica, MA, USA). Anti-alpha-
internexin and anti-chloride intracellular channel protein antibodies were procured from 
Santa Cruz (Dallas, TX, USA). Amersham ECL IgG horseradish peroxidase-linked 
secondary antibodies, ECL-Plus Western blotting chemiluminescent detection reagents as 
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well as Re-Blot Plus Strong stripping solutions were purchased from GE Healthcare 
(Pittsburgh, PA, USA).
2.1. Animals
Twenty-three adult (7–13 years old) male rhesus monkeys (Macaca mulatta) were housed at 
the NIH Animal Center, Poolesville, MD, a center fully accredited by the American 
Association for Accreditation of Laboratory Animal Care. All procedures were approved by 
the Animal Care and Use Committee of the NIA Intramural Program.
2.1.1. Experimental diet—Monkeys were randomized into one of three groups: a healthy 
standard diet (Cont, n=3) or a high fat/high sugar diet in combination with either placebo 
(HFS, n=10) or resveratrol (HFS+RSV, n=10). The Cont diet was a standard purified chow 
consisting of 13% of kcal in fat and <5% sucrose by weight (Purina Mills, St. Louis, MO, 
USA). The HFS diet was a specially formulated purified ingredient diet with 42% of kcal in 
fat and approximately 27% sucrose by weight (Harlan, Teklad, Indianapolis, IN, USA). The 
monkeys were gradually switched to the HFS diet over a 3-week period. Monkeys received 
two meals per day at estimated ad libitum levels throughout the study and water was always 
available. The average food consumption (kcals/day) for weekly periods was the same for all 
groups.
The RSV dose was derived from the protective dose reported in mice (22 mg/kg) [15] and 
adjusted by allometric scaling to an average monkey body weight of 12.1 kg. RSV was 
supplied by DSM Nutritional Products, Parsippany, NJ. HFS+RSV monkeys received 40 mg 
RSV twice a day for the first year which was increased to 240 mg twice a day during the 
second year in order to raise plasma RSV levels. The HFS and Cont monkeys received a 
placebo treat (Bio-Serv, Frenchtown, NJ, USA). Additional experimental details have been 
described previously [16–18].
2.1.2. Sacrifice and tissue harvest—Anesthesia was induced with Ketamine (7–10 
mg/kg, IM) and, following blood collection, the monkeys were deeply anesthetized with a 
lethal dose of sodium pentobarbital (50 mg/kg, IP). Once maximally sedated, the monkeys 
were perfused with cold lactated Ringer's solution. Tissues were harvested immediately, 
flash frozen in liquid nitrogen, and stored at −80 °C until use.
2.2. Sample preparation
The parietal lobules from the brains of rhesus monkeys were thawed at 4 °C and individual 
homogenates were prepared with a Wheaton glass homogenizer (approximately 40 passes) 
with ice-cold isolation buffer [0.32 M sucrose, 2 mM EDTA, 2 mM EGTA, 20 mM HEPES, 
0.2 µg/ml PMSF, 4 µg/ml leupeptin, 4 µg/ml pepstatin, 5 µg/ml aprotinin]. Homogenates 
were thoroughly vortexed and subsequently sonicated on ice for 10 s at 20% power, a total 
of two times, allowing the sample to rest 20 s on ice between vortexings, with a Fisher 550 
Sonic Dismembrator (Pittsburgh, PA, USA). Concentration of the total protein in the 
homogenates was determined by the Pierce BCA method (Rockford, IL, USA).
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2.3. Two-dimensional polyacrylamide gel electrophoresis (2-D PAGE)
2.3.1. Isoelectric focusing (IEF)—Brain tissue homogenates (200 µg) were shaken in 
200 µl of rehydration buffer [8 M urea, 2.0% (w/v) CHAPS, 2 M thiourea, 50 mM DTT, 
0.2% biolytes, 0.01% bromophenol blue] for 1.5 h at RT and then sonicated for 10 s at 20% 
power. Samples were applied to 11 cm pH 3–10 ReadyStrip™ IPG strips with a linear 
gradient. IPG strips were actively rehydrated at 20 °C for 18 h at 50 V using a Bio-Rad 
Protean IEF Cell (Hercules, CA, USA). After the first 60 min, 2 mL of mineral oil was 
added to the strips. Next, isoelectric focusing was carried out at a constant temperature of 
20 °C beginning at 300 V for 2 h, 500 V for 2 h, 1000 V for 2 h, 8000 V for 8 h, and ending 
at 8000 V for 10 h. The IPG strips were immediately stored at −80 °C until use.
2.3.1.1. SDS page: IPG strips were thawed for 10 min and then 4 ml of a DTT-containing 
equilibration buffer [50 mM Tris–HCl, pH 6.8, 6 M urea, 1% (w/v) SDS, 30% v/v glycerol, 
0.5% DTT]was added for 10 min in the dark. This solution was removed and 4 ml of an 
iodoacetamide-containing buffer [50 mM Tris–HCl, pH 6.8, 6 M urea, 1% (w/v) SDS, 30% 
v/v glycerol, 4.5% iodoacetemide] for 10 min in the dark. IPG strips were then rinsed in a 
1× dilution of TGS running buffer and placed into Criterion precast linear gradient (8–16%) 
Tris–HCl polyacrylamide gels. Precision Plus Protein™ All Blue molecular weight marker 
was added and agarose gel was overlaid. Gels were run at a constant voltage of 200 V for 
approximately 65 min until completion using 1× Tris/Glycine/SDS running buffer.
2.4. SYPRO ruby staining
Following 2D–PAGE, gels were fixed in solution [7% (v/v) acetic acid, 10% (v/v) methanol] 
(50 ml) for 45 min at RT on a gently orbiting platform. Next, the fixing solution was 
removed and 50 ml of Sypro Ruby Protein Gel Stain was added and stained proteins in the 
gel overnight (15 h) at RT with gentle orbiting. Gels were rinsed and transferred to 50 ml of 
deionized water at RT until scanning. Gels were scanned using a Bio-Rad ChemiDoc XRS+ 
imaging system (Hercules, CA, USA) and stored in deionized water at 4 °C until extraction 
of protein spots.
2.5. Image analysis
Spot intensities of the imaged SYPRO Ruby-stained 2D gels were quantified by 
densitometry using PDQuest 2-D Analysis Software (Bio-Rad, Hercules, CA, USA). 
Individual gel spot intensities were normalized to the total density of the respective gel. Spot 
densities from the three sample groups (Cont, HFS, HFS+RSV) were compared and spots 
with a statistically significant difference based on a Student's two-tailed t test (P<.05) were 
considered for in-gel trypsin digestion and the subsequent identification of the protein.
2.6. In-gel trypsin digestion and peptide extraction
Statistically significant protein spots were excised from 2D-gels and transferred to 
Eppendorf microcentrifuge tubes. Next, 20 µL of 0.1 M ammonium bicarbonate 
(NH4HCO3) was added to each tube and incubated at RT for 15 min, followed by an 
addition of 30 µL of acetonitrile at RT for 15 min. The solvent was removed and gel plugs 
dried at RT for approximately 30 min. Then, 30 µl of 20 mM DTT in 0.1 M NH4HCO3 was 
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added to the gel plugs and incubated for 45 min at 56 °C. After removal of the DTT/
NH4HCO3 solution, 30 µl of 0.05 M iodoacetamide (IA) in 0.1 M NH4HCO3 was added and 
gel plugs incubated at RT for 15 min. The IA solution was then removed and 150 µl of 0.05 
MNH4HCO3 was added to incubate for 15 min at RT. Next, 200 µl of acetonitrile (ACN) 
was added to this solution and incubated for an additional 15 min. Gel plugs were dried for 
30 min at RT before rehydrating with 10 µl of modified trypsin solution in 0.05MNH4HCO3. 
Plugs were incubated at 37 °C and shaken at 230 RPMs for 15 h. The digest solution was 
transferred into a new Eppendorf tube and then 20 µl of a 5% ACN, 0.1% formic acid (FA) 
solution was added to the old tube containing the gel plug and sonicated in a bath for 15 
min. To this, 30 µl of a 95% ACN, 0.1% FA and 0.001 M NH4CO3 solution was added and 
sonicated for 15 min. The solution was removed from the gel plug tube and combined with 
the supernatant digest solution. Using a Speedy Vac, the samples were subsequently 
concentrated to a volume of approximately 10 µl. Salts and contaminants were removed 
from the trypsin-digested peptide solution with C18 ZipTips. 10 µl of 100% ACN was 
aspirated into the tip and expelled a total of 5 times. Next, 10 µl of a 50% ACN solution 
containing 0.1% FA was aspirated and ejected a total of 5 times. The trypsin digested 
solution was then slowly drawn up and pushed gently out of the column a total of 10 times 
for peptide adherence. The contaminants were eliminated from the peptides in the ZipTip by 
washing with 10 µl of a 5% ACN and 0.1% FA solution a total of 3 times. Peptides were 
extracted from the column with 10 µl of a 50% ACN and 0.1% FA solution by slowly 
drawing up and expelling the eluent a total of 5 times. Samples were stored at −80 °C until 
MS analysis.
2.7. NanoLC-MS with data dependent scan
The de-salinated samples were reconstituted in 10 µL 5% ACN/0.1% FA and analyzed by a 
nanoAcquity (Waters, Milford, MA)-LTQ Orbitrap XL (Thermo Scientific, San Jose, CA, 
USA) system in data dependent scan mode. An in-house packed capillary column (0.1 × 130 
mm column packed with 3.6 µm, 200 Å XB-C18) and a gradient with 0.1% FA and ACN/
0.1% FA at 200 nL/min were used for separation. The MS spectra were acquired by the 
orbitrap at 30,000 resolution and MS/MS spectra of the six most intense ions in MS scan 
were obtained by the orbitrap at 7500 resolution. Data files from each sample were searched 
against the most current version of the Swiss-Prot database by SEQUEST (Proteome 
Discoverer v1.4, Thermo Scientific). A minimum of two high-confidence peptide matches 
were required for protein identification (false discovery rate <1%). Proteins matched with 
the same peptides are reported as one protein group. Resultant MS/MS data were initially 
verified by comparison of the expected molecular weight and isoelectric point of the 
identified protein to that of the extracted plug from the 2-D gel.
2.8. 1-D western blotting validation
2.8.1. One-dimensional polyacrylamide gel electrophoresis (1D–PAGE)—
Parietal lobule homogenates (50 µg) were suspended in 4× sample loading buffer [0.5 M 
Tris, pH 6.8, 40% glycerol, 8% SDS, 20% β-mercaptoethanol, 0.01% Bromophenol Blue] 
diluted to 1× with distilled water. Samples were then heated at 95 °C for 5 min, cooled on 
ice and loaded into a Criterion precast (4–12%) Bis-Tris polyacrylamide 12 well gel with 
Precision Plus Protein All Blue Standards. Gels were run at RT in a Criterion Cell vertical 
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electrophoresis buffer tank (Bio-Rad, Hercules, CA, USA) containing a 1× dilution of XT 
MOPS running buffer at 80 V for 15 min. Voltage was then increased to 120 V for the 
duration of the electrophoretic run (approximately 100 min).
2.8.2. 1D–western blotting—Proteins in the gel were transferred to a nitrocellulose 
membrane (0.2 nm) using a Trans-Blot Turbo™ Blotting System (Bio-Rad, Hercules, CA, 
USA). After the transfer, membranes were placed in a blocking solution of 3% bovine serum 
albumin (BSA) in Wash Blot [150 mM NaCl, 3 mM NaH2PO4, 17 mM NaHPO4 and 0.04% 
(v/v) Tween 20] at RT for 1.5 h. Alpha-internexin and anti-chloride intracellular channel 
proteins were detected with polyclonal primary antibodies raised in rabbits (1:8000 dilution 
in blocking solution.) Blots were incubated at RT with gentle rocking for 2 h. Next, the 
membranes were rinsed three times in Wash Blot (5 min, 5 min, 10 min), followed by a 1 h 
incubation with a rabbit horseradish peroxidase (1:3000) secondary antibody at RT with 
gentle rocking. Blots were rinsed three times (5, 10 and 10 min) in Wash Blot and developed 
chemiluminescently using Clarity™ Western ECL Substrate. After developing for 5 min at 
RT in the dark, blots were scanned using a Bio-Rad ChemiDoc™ XRS+ imaging system and 
quantified using Image Lab software (Bio-Rad, Hercules, CA, USA). The membranes were 
then rinsed with Wash Blot for 5 min, two times, and then stripped with Re-Blot Plus Strong 
solution for exactly 10 min at RT, followed by three 5 min rinses with Wash Blot. The 
membranes were then blocked once again in 3% BSA for 1.5 h. Next, anti-tubulin antibodies 
raised in mice (1:20,000) were added to the Wash Blot solution for 2 h of gentle rocking at 
RT. Membranes were then washed, incubated with a secondary HRP-conjugated antibody, 
washed, developed chemiluminescently and scanned as described above.
2.9. Statistical analysis
An ANOVA was performed followed by a Bonferroni correction for multiple comparisons in 
order to determine the effects of HFS and HFS+RSV diets on the expression of proteins 
within the tissue of the parietal lobule. An α<0.05 was selected as a measure of significance 
for the ANOVA while a P<.05 was selected as a measure of significance for the multiple 
comparisons test. Fold-change values of differentially expressed proteins were determined 
by dividing the average spot intensity of the gels from the HFS or HFS+RSV diet groups by 
the average spot intensity of the gels of the Cont diet group. For the fold-change 
comparisons between the HFS and the HFS+R, the average spot intensities of the gels from 
the HFS+RSV were divided by those of the gels from the HFS diet. Proteins that were 
identified by the SEQUEST search algorithm with P<.01 were considered to be statistically 
significant. To further validate MS/MS identification of significant differentially expressed 
proteins, the position of protein spots on the 2D–gel images were manually examined to 
confirm that they were located near the expected molecular weight and isoelectric point 
values from the SwissProt database information.
3. Results
3.1. Proteomics
Proteomic identifications of proteins from rhesus monkey parietal lobules following 2 years 
of a diet intervention were conducted using a 2D–PAGE approach with Sypro Ruby staining. 
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Protein spot intensities were compared between these three groups to determine 
differentially expressed proteins. Fig. 1 shows representative examples of 2-D gel images of 
the isolated proteins for the Cont and HFS comparison with the five differentially expressed 
proteins identified and listed in Table 1. Gel images for the Cont and HFS+RSV comparison 
are shown in Fig. 2. Six proteins were identified and listed in Table 2. Fig. 3 illustrates the 
four differentially expressed proteins between HFS and HFS+RSV diet groups which are 
listed in Table 3. PDQuest analysis of 2-D images for all three groups identified protein 
spots suitable for extraction and whose expression was significantly altered in the parietal 
lobules, and five of the proteins were significant in multiple comparisons. Protein spot 
extraction was followed by in-gel trypsin digestion, peptide extraction, removal of metal 
ions with buffers, and MS/MS analysis coupled to interrogation of protein databases. All 
proteins were identified by more than one peptide sequence.
Fold-change values were calculated by dividing the average spot intensity of the gel protein 
spots of the HFS or HSF+RSV diet group by the average spot intensity of the Cont diet gel 
spots, or by dividing the average spot intensity of the gel protein spots of the HFS+RSV by 
the average spot intensity of the gel protein spots of the HFS diet. To expound, a fold 
increase of 1.75 in the HFS+RSV group represents a 75% increase in protein level of the 
HFS+RSV group compared to the group used as a Cont in the comparison. Moreover, a fold 
value <1, denotes a decrease in protein level; for example, a fold-change of 0.25 represents a 
decreased protein level of 75%.
3.2. Western blot validation experiments
Western blot experiments were conducted on a selected protein to validate the changes in 
protein levels as determined by the PDQuest analysis of the 2-D gels. Fig. 4 is a Western 
blot image of the three groups after probing with chloride intracellular channel protein and 
tubulin antibodies. Analysis of this blot showed a 65.6% decrease in levels of chloride 
intracellular channel protein in the HFS group compared to Cont (P=.008), as well as a 
72.3% decrease in HFS+RSV compared to Cont (P=.0051). PDQuest data from the protein 
spot identified as chloride intracellular channel protein by MS/MS analysis showed a 98.7% 
decrease in levels from the Cont diet to the HFS diet (P=.0234), and a 62.77% decrease in 
levels from the Cont diet to the HFS+RSV diet (P=.0294). Fig. 5 is the Western blot image 
of the samples after probing with a primary alpha-internexin antibody, whereas tubulin was 
the loading control. The HFS group demonstrated only a trend (P=.059) toward a decrease 
compared to Cont despite a 32.8% reduced levels of alpha-internexin. HFS+RSV had a 
41.7% increase in levels of alpha-internexin compared to the HFS group (P=.0159) but was 
not different from Cont. The variations in fold changes between the two detection methods 
may be attributed to the sensitivity of the Sypro Ruby staining method of the 2-D gels 
contrasted to the range limitations involved with the chemiluminescent development of the 
1-D Western blot. These validation experiments support the findings in the proteomics 
identification of the main proteins in the study.
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4. Discussion
Discovery-based expression proteomics was used to compare the effects of three 
experimentally controlled dietary conditions in adult male rhesus monkeys: a standard 
healthy control diet, a Westernized diet high in fat and sugar, and the HFS diet supplemented 
with RSV. Eleven proteins were identified in the HFS groups with a significant differential 
expression when compared to Cont diet monkeys. The functions of these proteins vary 
greatly but all can be considered contributing to the proper functioning of biological systems 
such as metabolism, structural integrity, neurotransmission, and cellular signaling. RSV's 
greatest effects reportedly occur within a metabolically impaired state such as obesity and 
diabetes, while healthy individuals benefit less [19–23]. A recent study published by 
collaborators using the monkeys from which our samples were derived measured the levels 
of RSV in the CSF of HFS+R, but were unable to detect RSV in the Cont and HFS groups 
demonstrating the efficacy of the RSV supplementation [24]. Moreover, they were able to 
measure SIRT1 and SIRT2 levels and activity (via acetylated tubulin). While it was found 
that SIRT1 levels were unchanged across the three groups, the HFS+R group had a 
significant reduction in SIRT2 levels that accompanied an increase in expression of α-
tubulin and a reduction in the ratio of acetylated tubulin/total tubulin, of which the authors 
suggest may be due to compensatory mechanisms of acetylation [24].
Here, we identified a number of parietal lobe proteins of differential levels in monkeys 
consuming an HFS diet for 2 years. In several, but not all cases RSV supplementation was 
associated with a change in the expression profile suggestive of improved function. Those 
proteins exhibiting level changes associated with treatment are classified here by cellular 
sub-systems and discussed in that context. A graphical illustration of the protein and a 
primary canonical function is provided in Fig. 6.
4.1. Energy
The production and maintenance of cellular stores of energy is a complex and necessary 
function of all systems within an organism, however, the brain is unique in its energy 
consumption needs. The brain is a small fraction of the total mass of an organism, yet it 
consumes upwards of 30% of all inspired oxygen and 20% of ingested glucose for its energy 
needs. This energy is used to maintain neuronal cell resting potentials, neurotransmitter 
production and release, as well as the propagation of action potentials, among other 
functions. Moreover, the brain is highly dependent upon glucose for its functioning, and any 
severe decrease in glucose metabolism may prove to be detrimental to the health of the 
organism. Therefore, an analysis of proteomic changes to the levels of metabolic enzymes as 
a function of diet could prove useful in understanding the effects of a Western diet and/or 
resveratrol supplementation on the brain.
A number of glycolytic enzymes were identified as having altered protein levels. Pyruvate 
kinase and phosphoglycerate kinase 1 were significantly decreased (0.11-fold and 0.71-fold, 
respectively) in the HFS group compared to Cont. As glucose is the primary source of 
energy for the brain, we posit that the observed decrease in these two glycolytic enzymes 
following 2 years on HFS diet represent energy impairment imparted by the unhealthy diet. 
Resveratrol supplementation to an HFS diet appeared to preferentially act on ENO1 levels as 
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alpha-enolase (ENO1) was 3.15-fold higher in the HFS+RSV compared to HFS group. 
ENO1, is most commonly known for its role in glycolysis in which it catalyzes the 
production of phosphoenolpyruvate from 2-phosphoglycerate. A loss of glycolytic enzymes 
could potentially have a negative effect on the efficiency of glucose utilization and thus, 
normal brain function. However, ENO1 is a pleiotropic enzyme with many functions beyond 
glucose metabolism. ENO1 has been shown to exhibit functions of a heat shock protein, a 
hypoxic-stress protein, a neurotrophic factor, as well as a transcription modulator [25]. 
Enolase has been found to be compromised in several neurodegenerative diseases such as 
AD, Huntington's disease, and amyotrophic lateral sclerosis [26–28].
BACH protein was 58.2-fold lower in the HFS monkey parietal lobe compared to Cont. 
BACH cleaves acyl-CoA into coenzyme-A (CoASH) and the resultant fatty acid. Fatty acids, 
acyl-CoA, and CoA-SH all serve diverse biological functions important in processes such as 
β-oxidation and metabolism in general, lipid synthesis, gene regulation, cellular signaling, 
and enzymatic regulation. Additionally, within the brain, they serve as an energy source, and 
in the process of lipid synthesis and homeostasis, cellular signaling, enzyme regulation, 
vesicle trafficking, and gene expression, bio-molecular trafficking, and ion flux [29–32]. 
BACH has been found to be crucial in preventing neurotoxicity via dysregulation of fatty 
acid metabolism while also regulating cell and membrane stability, potentially impacting the 
aging rate [30,33]. BACH is more active in the brain than in any other organ system and our 
data suggest that long-term consumption of an HFS diet by a nonhuman primate may impair 
its expression levels. This finding may have direct implications on healthy brain function as 
previous research has indicated that functioning BACH provides protection from 
neurotoxicity [32].
4.2. Structure
Microtubules are structural protein complexes that provide structural integrity to the cell, as 
well as roles in cellular processes such as cell division, ciliary/flagellar movement, and 
intracellular transport. Microtubules are composed of alpha- and beta-tubulin that self-
assemble into large polymers. However, due to rapidly changing complex needs of the cell, 
microtubules must be dynamic in their construction and deconstruction. Stathmin is a key 
protein in the regulation of microtubule assembly and disassembly and impedes formation of 
microtubules through the sequestration of soluble tubulin into T2S complexes [34]. 
Therefore, the levels of stathmin may directly affect microtubule turnover and dynamics. 
Moreover, an overexpression of stathmin is found to be present in various forms of cancers 
and in AD progression, while also being positively correlated to telomere shortening 
[35,36]. In the current study, monkeys fed HFS+RSV have a 0.69-fold decrease of stathmin 
compared to HFS fed monkeys. This decrease in stathmin may allow for increased 
microtubule formation and stability, consistent with more efficient intracellular transport of 
vesicles and mitochondria.
Collapsin response mediator protein-2 (CRMP-2; also called dihydropyrimidinase-related 
protein 2 (DRP-2)) is important in the proper functioning of neurons, and its aberrant 
expression and/or inactivity has been implicated in neurodegenerative diseases such as AD 
[37,38]. The primary roles of CRMP-2 are control of the dynamic stability of microtubules, 
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neural differentiation and specification for axons and dendrites, the proper outgrowth/
retraction of neurites, neurotransmitter release, indirect control of axonal transport, and 
calcium homeostasis [37,39–42]. CRMP-2 is the only CRMP to be maintained at high levels 
in adult neurons and is mostly expressed in areas requiring high degrees of plasticity such as 
the hippocampus, cerebellum, and olfactory bulb [43]. Within the neuron, CRMP-2 is found 
within the growth cone and synapses, indicative of its function [44]. Here, we showed that 
levels of CRMP-2 are significantly reduced in HFS and HFS+RSV compared to Cont at 
0.079-fold and 0.098-fold, respectively. These data indicate that CRMP-2 may be decreased 
in response to a HFS, unhealthy diet and RSV was not protective in monkeys. The 
implementations of this reduced level is that neuritic extensions would be shorter, thereby 
making fewer synaptic connections. HFS could therefore lead to detrimental cognitive 
changes.
Oligodendrocytes are one of the major cell types of the CNS as a component of the myelin 
sheath, wrapping around the adjacent neuronal axons to allow saltatory impulse propagation. 
Oligodendrocytes are associated with 2,3-cyclic nucleotide 3-phosphodiesterase (CNP), 
which plays an important, albeit not well understood, role in myelin formation. CNP is 
located in non-compacted myelin regions while absent in compacted sheath [45,46]. Lappe-
Seifke et al. silenced the Cnp1gene in mice, which resulted in fully myelinated offspring, but 
with severe axonal swelling and death by 12 months [47]. In Cnp-1 null mice, the absence of 
CNP led to disorganized oligodendroglial paranodes and altered communication between 
neuronal axons and oligodendrocytes and consequential neurodegeneration [48]. In our HFS
+RSV fed nonhuman primates, CNP was down regulated 0.492-fold compared to the HFS-
fed group indicating that RSV supplementation appears to have a detrimental impact on 
CNP performance.
Vacuolar H+–ATPases (V-Type ATPase) have a structure and mechanistic action similar to 
that of F-Type ATPases, which are found in the inner mitochondrial membrane and used for 
oxidative phosphorylation, yet the ultimate function they perform differs. While F-Type 
ATPases use proton gradients to drive ATP production, V-Type ATPases use ATP to drive 
proton gradients [49]. The establishment of an electrochemical proton gradient across a lipid 
bilayer is used in a variety of processes from the acidification of lysosomal luminal space, to 
the packaging of neurotransmitters into synaptic vesicles and endocytic transportation [50]. 
For instance, the environment of an endocytic vesicular lumen made acidic in comparison to 
the surrounding cytosol by V-Type ATPases allows for the dissociation of ligands and 
receptors for recycling of the components [51]. In regards to protein degradation and 
turnover, V-Type ATPases play an important role in the autophagic pathway in direct and 
possibly indirect manners. First, V-Type ATPases directly acidify the lysosomal luminal 
space to a pH of around 4.5 in order to provide an optimal environment for lysosomal 
protease functioning [50,52]. A less well characterized function of V-Type ATPases in 
regards to induction of autophagy is their proposed ability to activate lysosomal bound 
mTORC1, a required step for mTORC1 activation. It is hypothesized that due to V-Type 
ATPases interaction with both mTORC1 and Regulator, that V-Type ATPases may sense 
levels of available amino acids and convey that information to mTORC1 [53–55]. In this 
study, we found a significant increase in isoform 3 of V-Type proton ATPase subunit E-1 
protein level (4.67-fold) in the HFS+RSV group compared to Cont. We hypothesize that an 
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increase in V-Type ATPase levels with RSV supplementation represents the cellular attempt 
at an autophagy response as needed while preserving the necessary brain functions such as 
neurotransmitter processing and lysosomal efficacy.
4.3. Signaling
One method of signal transduction is through the activation of transmembrane G-protein 
coupled receptors (GPCRs). GPCRs participate in many signaling and physiological 
functions such as neurotransmission, peptide hormone signaling, vision, taste, and smell 
[56]. GPCRs have a small G-protein docked to the intracellular side of the receptor, which 
upon receptor activation is itself activated by the replacement of GDP with GTP in its 
regulatory site causing the G-protein to split into Gα and Gβγ subunits. Upon activation of 
the Gα-subunit by GTP, the Gα-subunit is free to activate downstream effectors such as 
adenylate cyclase (AC), a signal amplifying enzyme that creates the secondary messenger 
cyclic-AMP (cAMP) from ATP. Following this process, the Gα-subunit's GTPase activity 
slowly turns the GTP back to GDP, deactivating itself to start the cycle anew. Guanine 
nucleotide-binding protein (Gi/Gs/Gt)-1 (GNB1), the β subunit, is responsible for the 
GTPase activity, which allows for the activation of the G-protein, guanine nucleotide 
exchange, and also for downstream signaling of the Gβγ complex [57]. In the present study, 
the HFS+RSV diet led to an increase in GNB1 by 3.61-fold over that of the brain of 
monkeys fed the HFS diet alone, whereas GNB1 was found to have a significant decrease in 
levels (0.07-fold) in the HFS compared to Cont. The results suggest that while the HFS diet 
alone may have a detrimental role in levels of GNB1, RSV may attenuate that loss, 
suggestive of a protective effect. GNB1 is necessary for the direct activation of downstream 
effects such as phosphoinositide-3-kinase, phospholipase-C isoforms, and ion channels, 
while indirectly participating in all Gα activities due to their regulatory nature over the Gα 
subunit [58]. Here, our proteomics studies are consistent with the notion that addition of 
RSV to a HFS diet promotes cellular signaling in brain that is diminished in brain of HFS-
fed monkey group.
Glutamine synthetase is a key protein of astrocytes in the brain as it is involved in the 
glutamate-shuttle and subsequent conversion of the neurotransmitter glutamate to inactive 
glutamine prior to being translocated back to the neuron. The glutamate shuttle is important 
for the health of the neuron as glutamate is an excitatory neurotransmitter which if left in the 
synapse and not converted to glutamine may cause excitotoxicity and subsequently neuron 
death through calcium dysregulation [59]. However, the glutamine shuttle is not solely 
responsible for glutamate availability at the synapse [60]. We report that glutamine 
synthetase has significantly reduced levels (0.74-fold) in the HFS+RSV when compared to 
Cont, and decreased but not significantly decreased levels in HFS compared to Cont 
suggesting that the HFS diet depressed levels of glutamine synthetase that are not recovered, 
and perhaps even exacerbated, with RSV supplementation. It has been suggested in a 3×–
TG-AD mouse model that depression of glutamine synthetase levels may lead to errant 
glutamate homeostasis and regulation as well as memory and cognitive impairment that may 
be attributed to failures in synaptic connectivity, all of which are apparent in human AD 
[61].
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Chloride intracellular channel protein 4 (CLC-4) is a multifunctional protein predominantly 
known for its role as a chloride channel, as its name implies. However, CLCs have recently 
been shown to participate in other physiological roles such as a mediator of apoptosis in 
which this protein is translocated to the nucleus [62,63]. The suppression of CLC-4 with 
siRNA is reported to be involved in enhanced hydrogen peroxide mediated apoptotic 
activation [64], whereas others showed siRNA interference of CLC-4 enhanced TNFα-
mediated apoptosis in a p53-independent manner [65]. However, the role of CLC-4 in 
apoptosis is complex, as demonstrated by its ability to be highly apoptotic in and of itself 
when Apaf1 is deleted, inhibiting the mitochondrial apoptotic pathway [66]. Here, we show 
a significant decrease in CLC-4 in both the HFS vs Cont and HFS+RSV vs Cont groups 
with 0.01-fold and 0.37-fold protein level of control, respectively. We posit that this decrease 
in CLC-4 levels in both unhealthy diet groups is indicative of potential apoptotic regulation, 
and as oxidative stress is a hallmark of both diabetes and AD, it is possible that hydrogen 
peroxide mediated apoptosis is in part responsible for cognitive deficiencies, though follow-
up research is needed to clarify this speculation.
SH3 domain-binding glutamic acid-rich-like protein (SH3BGRL) is homologous to 
glutaredoxin 1 in E. coli, an oxioreductase, thought to belong to the thioredoxin-like protein 
family [67]. SH3BGRL2, a homolog of the SH3BGRL family, was later identified and 
shown to have a high similarity to other SH3BGRL homolog N-terminal region [68]. While 
SH3BGRL proteins may belong to the thioredoxin-like super family of proteins, all 
homologs are devoid of the CXXC motif indicating that they most likely do not have any 
thioredoxin-like enzymatic activity [68]. However, due to its shared homology, specifically 
to that of glutaredoxin, it is possible that SH3BGRL proteins participate in the regulation of 
redox sensitive proteins, possibly through the action of its PICOT homology domain, 
allowing it to engage in protein–protein interactions hinting at its role as a protein regulator 
[68]. Research supports the notion of SH3BGRL protein SH3BGRL3 as acting as an indirect 
inhibitor of TNF-α through the activation of NF-κB by way of its PICOT homology [69,70]. 
Here we observed a decreased level of SH3BGRL2 (0.69-fold) in HFS+RSV diet fed 
monkeys vs Cont monkeys. As both SH3GBRL2/3 share similar PICOT homology, it is 
possible that RSV supplementation in an HFS diet modulates the inflammatory response 
through SH3BGRL2/3 decrease of active TNF-α and subsequently modulating the 
inflammatory response, though this speculation needs further study to confirm.
5. Conclusion
Using proteomics, we have identified a number of proteins with differential expression in the 
parietal lobule of adult male rhesus monkeys fed Cont, HFS or HFS+RSV diets over a 
duration of two years. Our findings suggest potential improvements in energy metabolism, 
efficiency of canonical cell signaling pathways, and neurotransmission with RSV 
supplementation to an HFS diet. In contrast, some brain protein levels such as CNP and 
glutamine synthetase may not be attenuated by RSV supplementation of an unhealthy diet. 
While it has been shown in other studies that resveratrol addition to a normal diet may not 
provide significant benefits to healthy individuals, it has been observed that resveratrol does 
lead to marked improvement in individuals already exhibiting signs of metabolic syndrome 
[19,21,22]. Our studies contribute to the understanding of the changes occurring in the 
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proteome of the dietary-impaired parietal lobule of non-human primates given resveratrol 
supplementation.
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Fig. 1. 
Representative 2-D gel image with identified protein spots for the Cont vs. HFS fed diet 
comparison.
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Fig. 2. 
Representative 2-D gel image with identified protein spots for the Cont vs. HFS+RSV fed 
diet comparison.
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Fig. 3. 
Representative 2-D gel image with identified protein spots for the HFS vs. HFS+RSV fed 
diet comparison.
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Fig. 4. 
Western blot validation of CLC-4 levels across each group normalized against tubulin (**P≤.
01).
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Fig. 5. 
Western blot validation of alpha-internexin levels across each group normalized against 
tubulin (*P≤.05).
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Fig. 6. 
The above figure outlines the proteins and canonical functions of those found to be of 
differentially expressed in the present study. Proteins identified within this study are labelled 
in red.
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